Molecular Virology: Tables of Antimicrobial Factors and Microbial Contaminants in Human Milk
Selected bibliography to tables - Table 7

• Ando Y., Ekuni Y., Matsumoto Y., Nakano S., Saito K., Kakimoto K., Tanigawa T., Kawa M., and Toyama T. (2004) Long-term serological outcome of infants who received frozen-thawed milk from human T-lymphotropic virus type-1 positive mothers. J. Obstet. Gynaecol. Res., 30, 436-438.
• Arnold LDW., and Larson E. (1993) Immunologic benefits of breast milk in relation to human milk banking. Am. J. Infect. Control, 21, 235-242.
• Bjorksten B., Burgman LG., De Chateau P., Frerikzon B., Gothefors L., and Hernell O. (1980) Collecting and banking human milk: To heat or not to heat? Brit. Med. J., 2, 765-769.
• British Paediatric Association. (1993) Guidelines for the establishment and operation of human milk banks in the UK.
• Bryant P., Morley., Garland S., and Curtis N. (2002) Cytomegalovirus transmission from breast milk in premature babies: does it matter? Arch. Dis. Child Fetal Neonatal Ed., 87, F75-F77.
• Brown NM., Arbon J., and Redpath C. (2000) Contamination of milk-bank samples with Pseudomonas aeruginosa during pasteurisation by penetration of organisms through the screw lid during cooling. J. Hosp. Infect., 46, 321-322.
• Chen H-Y., and Allen JC. (2001) Human milk antibacterial factors. The effect of temperature on defense systems. Adv. Expt. Med. Biol., 501, 341-348.
• Curtis N., Chau L., Garland S., Tabrizi S., Alexander R., and Morley CJ. (2005) Cytomegalovirus remains viable in naturally infected breast milk despite being frozen for 10 days. Arch. Dis. Child. Fetal Neontal Ed., 90, F529-F530.
• Elgin RP., and Wilkinson AR. (1987) HIV infection and pasteurisation of breast milk. Lancet, i, 1093.
• Eyes R., Elliott RB., Howie RN., and Farmer K. (1978) Low-temperature pasteurisation of human milk. New Zealand Med. J., 87, 134-135.
• Ferreira CS., Martinho PC., Neto A., and Cruz RR. (2001) Pasteurisation of human milk to prevent transmission of Chagas disease. Rev. Inst. Trop. Sao. Paulo, 43, 161-162.
• Ford JE., Law BA., Marshall VME., and Reiter B. (1977) Influence of heat treatment of human milk on some of its constituents. J. Ped., 90, 29-35.
• George RH. (1997) Killing activity of microwaves. J. Hosp. Infect., 35, 319-320.
• Goldblum RM., Dill CW., Albrecht TB., Alford ES., Garza C., and Goldman AS. (1984) Rapid high temperature treatment of human milk. J. Ped. 104, 380-385.
• Gras-Le Guen C., Lepelletier D., Debillon T., Gournay V., Espaze E., and Roze JC. (2003) Contamination of a milk pasteuriser causing a Pseudomonas aeruginosa outbreak in a neonatal intensive care unit. Arch. Dis. Child. Fetal Neonatal Ed., 88, F434-435.
• Hamprecht K., Maschmann J., Muller D., Dietz K., Besenthal I., Goelz R., Middeldorp JM., Speer CP., and Jahn G. (2004) Cytomegalovirus (CMV) inactivation in breast milk: reassessment of pasteurization and freeze-thawing. Pediatr. Res., 56, 529-535.
• Hewitt JH. (1981) Possible bacteriological hazards associated with the use of raw (unheated) human milk for special care infants. International Institute of Refrigeration, 2, 99-106.
• Human Milk banking Association of North America (1998) Gudelines for the establishment and operation of a donor human milk Bank.
• Israel-Ballard K., Chantry C., Dewey K., Lonnerdale B., Sheppard H., Donovan R., Carlson J., Sage A., and Abrams B. (2005) Viral, nutritional and bacterial safety of flash-heated and Pretoria pasteurised breast milk to prevent mother-to-child transmission of HIV in resource-poor countries: A pilot study. J. Acquir. Immune Defic. Syndr. 40, 175-181.
• Jeffery BS., Soma-Pillay P., Makin J., and Moolman G. (2003) The effect of Pretoria pasteurisation on bacterial contamination of hand-expressed human breastmilk. J. Trop. Pediatr., 49, 240-244.
• Jeffery BS., Webber L., Mokhondo KR., and Erasmus D. (2001) Determination of the effectiveness of inactivation of human immunodeficiency virus by Pretoria pasteurisation. J. Trop. Ped., 47, 345-349.
• Jones CL., Jennison RF., and D'Souza SW. (1979) Bacterial contamination of expressed breast milk. Brit. Med. J., 2, 1320-1322.
• Lawrence RA. (2001) Milk banking.: The influence of storage procedures and subsequent processing on immunologic components of human milk. Adv. Nutr. Res., 10, 389-404.
• Lindermann PC., Forshaugen I., and Lindermann R. (2004) Characteristics of breast milk and serology of women donating breast milk to a milk bank. Arch. Dis. Child Fetal Neonatal Ed., 89, F440-441.
• Nduati RW., John GC., and Kreiss J. (1994) Postnal transmission of HIV-1 through pooled breast milk. Lancet, 344, 1432.
• Nwankwo MU., Offor E., Okolo AA ., and Omene JA. (1988) Bacterial growth in expressed breast-milk. Ann. Trop. Paediatr. 8, 92-95.
• Ogundele MO. (2000) Techniques for the storage of human breast milk: implications for anti-microbial functions and safety of stored milk. Eur. J. Pediatr., 159, 793-797.
• Orlando S. (1995) The immunologic significance of breast milk. J. Obstetric. Gynacol. Neonat. Nursing, 24, 678-683.
• Orloff SL., Wallingford JC., and McDougal JS. (1993) Inactivation of human immunodeficiency virus type 1 in human milk: Effect of intrinsic factors in human milk and of pasteurisation. J. Human Lactation, 9, 13-17.
• Pardou A., Serruys E., Mascart-Lemone F., Dramaix M., and Vis HL. (1994) Human milk Banking: Influence of storage processes and of bacterial contamination of some milk constituents. Biol. Neonate, 65, 302-309.
• Roberts SA., and Severn M. (1978) bacterial growthin raw and pasteurised milk. Brit. Med. J., 2, 1196-1197.
• Welsh JK., Arsenakis M., Coelen R., and May JT. (1979) Effect of antiviral lipids, heat, and freezing on the activity of viruses in human milk. J. Infect. Dis., 140, 322-328.
• Wills ME., Han VEM., Harris DA., and Baum JD. (1982) Short-time low-temperature pasteurisation of human milk. Early Human Develop., 7, 71-80.
• Wright KC., and Feeney AM. (1998) The bacteriological screening of donated human milk: Laboratory experience of British Paediatric Association's published guidelines. J. Infect., 36, 23-27.
• Yamato K., Taguchi H., Yoshimoto S., Fujishita M., Yamashita M., Ohtsuki Y., Hoshino H., and Miyoshi I. (1986) Inactivation of lymphocyte-transforming activity of human T-cell leukaemia virus type 1 by heat. Jpn. J. Cancer Res., 77, 13-15.